Search Results - "Sehested, Thomas S. G."

Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study by Seven, Ekim, Husemoen, Lise L N, Sehested, Thomas S G, Ibsen, Hans, Wachtell, Kristian, Linneberg, Allan, Jeppesen, Jørgen L

“…Being overweight or obese is associated with a greater risk of coronary heart disease and stroke compared with normal weight. The role of the specific adipose…”
Get full text

Diabetes and risk of peripheral artery disease in patients undergoing first-time coronary angiography between 2000 and 2012 - a nationwide study by Kamil, Sadaf, Sehested, Thomas S G, Carlson, Nicholas, Houlind, Kim, Lassen, Jens F, N Bang, Casper, Dominguez, Helena, Pedersen, Christian T, Gislason, Gunnar H

“…The risk of peripheral artery disease (PAD) in patients with diabetes mellitus (DM) and coronary artery disease (CAD) is an important and inadequately…”
Get full text

Utilization and Outcomes of Measuring Fractional Flow Reserve in Patients With Stable Ischemic Heart Disease by Parikh, Rushi V., Liu, Grace, Plomondon, Mary E., Sehested, Thomas S.G., Hlatky, Mark A., Waldo, Stephen W., Fearon, William F.

“…The use and clinical outcomes of fractional flow reserve (FFR) measurement in patients with stable ischemic heart disease (SIHD) are uncertain, as prior…”
Get full text

Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011 by Hansen, Peter Wæde, Sehested, Thomas S G, Fosbøl, Emil Loldrup, Torp-Pedersen, Christian, Køber, Lars, Andersson, Charlotte, Gislason, Gunnar H

“…Warfarin is a cornerstone for the prevention of thromboembolism in atrial fibrillation (AF), and several efforts have been taken to increase its usage and…”
Get full text

Frailty, Treatments, and Outcomes in Older Patients With Myocardial Infarction: A Nationwide Registry-Based Study by Christensen, Daniel Mølager, Strange, Jarl Emanuel, Falkentoft, Alexander Christian, El-Chouli, Mohamad, Ravn, Pauline B, Ruwald, Anne Christine, Fosbøl, Emil, Køber, Lars, Gislason, Gunnar, Sehested, Thomas S G, Schou, Morten

“…Background Guidelines recommend that patients with myocardial infarction (MI) receive equal care regardless of age. However, withholding treatment may be…”
Get full text

Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events by Sehested, Thomas S G, Bjerre, Jenny, Ku, Seul, Chang, Andrew, Jahansouz, Alison, Owens, Douglas K, Hlatky, Mark A, Goldhaber-Fiebert, Jeremy D

“…In the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) trial, the anti-inflammatory monoclonal antibody canakinumab significantly reduced the…”
Get more information

Trends in Use of Cardioprotective Medication in Peripheral Artery Disease: A Nationwide Study by Kamil, Sadaf, Sehested, Thomas S. G., Houlind, Kim, Lassen, Jens F., Gislason, Gunnar H., Dominguez, Helena

“…Background Guideline‐based cardioprotective medical therapy is intended to reduce the burden of adverse cardiovascular and limb outcomes in patients with…”
Get full text

Temporal Trends in Noncardiovascular Morbidity and Mortality Following Acute Myocardial Infarction by Christensen, Daniel Mølager, Strange, Jarl Emanuel, El-Chouli, Mohamad, Falkentoft, Alexander Christian, Malmborg, Morten, Nouhravesh, Nina, Gislason, Gunnar, Schou, Morten, Torp-Pedersen, Christian, Sehested, Thomas S.G.

“…BACKGROUNDDue to improved management, diagnosis, and care of myocardial infarction (MI), patients may now survive long enough to increasingly develop serious…”
Get full text

Risk and trajectory of premature ischaemic cardiovascular disease in women with a history of pre-eclampsia: a nationwide register-based study by Hallum, Sara, Basit, Saima, Kamper-Jørgensen, Mads, Sehested, Thomas S G, Boyd, Heather A

“…Abstract Aims Pre-eclampsia increases women’s lifetime risk of cardiovascular disease (CVD). Little is known about the trajectory of CVD after pre-eclampsia,…”
Get full text

Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction by Sehested, Thomas S G, Carlson, Nicholas, Hansen, Peter W, Gerds, Thomas A, Charlot, Mette G, Torp-Pedersen, Christian, Køber, Lars, Gislason, Gunnar H, Hlatky, Mark A, Fosbøl, Emil L

“…Guidelines differ in their recommendations on therapy to prevent gastrointestinal bleeding for patients treated with dual antiplatelet treatment (DAPT). We…”
Get full text

Does Estimated Pulse Wave Velocity Add Prognostic Information?: MORGAM Prospective Cohort Project by Vishram-Nielsen, Julie K.K., Laurent, Stephane, Nilsson, Peter M., Linneberg, Allan, Sehested, Thomas S.G., Greve, Sara V., Pareek, Manan, Palmieri, Luigi, Giampaoli, Simona, Donfrancesco, Chiara, Kee, Frank, Mancia, Giuseppe, Cesana, Giancarlo, Veronesi, Giovanni, Kuulasmaa, Kari, Salomaa, Veikko, Kontto, Jukka, Palosaari, Tarja, Sans, Susana, Ferrieres, Jean, Dallongeville, Jean, Söderberg, Stefan, Moitry, Marie, Drygas, Wojciech, Tamosiunas, Abdonas, Peters, Annette, Brenner, Hermann, Njolstad, Inger, Olsen, Michael H.

“…The Reference Values for Arterial Stiffness Collaboration has derived an equation using age and mean blood pressure to estimated pulse wave velocity (ePWV),…”
Get full text

Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study by Christensen, Daniel Mølager, Schjerning, Anne-Marie, Smedegaard, Lærke, Charlot, Mette Gitz, Ravn, Pauline B, Ruwald, Anne Christine, Fosbøl, Emil, Køber, Lars, Torp-Pedersen, Christian, Schou, Morten, Gerds, Thomas, Gislason, Gunnar, Sehested, Thomas S G

“…Outcomes after myocardial infarction (MI) improved during recent decades alongside better risk factor management and implementation of guideline-recommended…”
Get full text

Age- and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 2021 by Christensen, Daniel Mølager, Strange, Jarl Emanuel, Phelps, Matthew, Schjerning, Anne-Marie, Sehested, Thomas S.G., Gerds, Thomas, Gislason, Gunnar

“…Few studies have determined whether the declining incidence of myocardial infarction carries into the current decade, and how it is affected by age and sex. We…”
Get full text

Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 2016 by Kamil, Sadaf, Sehested, Thomas S G, Houlind, Kim, Lassen, Jens F, Gislason, Gunnar H, Dominguez, Helena

“…Abstract Aims Over the past decades, there have been improvements in the management of cardiovascular (CV) disease and risk factors. Long-term contemporary…”
Get full text

Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–2019 by Christensen, Daniel Mølager, Jørgensen, Sidsel Marie Bernt, El-Chouli, Mohamad, Phelps, Matthew, Schjerning, Anne-Marie, Sehested, Thomas S G, Gerds, Thomas, Sindet-Pedersen, Caroline, Biering-Sørensen, Tor, Torp-Pedersen, Christian, Schou, Morten, Gislason, Gunnar

“…Abstract Background Influenza vaccination protects against morbidity and mortality in patients with cardiovascular disease (CVD). We aimed to describe…”
Get full text

Identifying Drug-Drug Interactions by Data Mining: A Pilot Study of Warfarin-Associated Drug Interactions by Hansen, Peter Wæde, Clemmensen, Line, Sehested, Thomas S G, Fosbøl, Emil Loldrup, Torp-Pedersen, Christian, Køber, Lars, Gislason, Gunnar H, Andersson, Charlotte

“…Knowledge about drug-drug interactions commonly arises from preclinical trials, from adverse drug reports, or based on knowledge of mechanisms of action. Our…”
Get full text

Temporal trends in major cardiovascular events following first-time myocardial infarction in the reperfusion era – a Danish nationwide cohort study from 2000 to 2017 by Ravn, Pauline Bohsen, Falkentoft, Alexander Christian, Garred, Caroline A H, Bruhn, Jonas, Christensen, Daniel Mølager, Sehested, Thomas S G, Gislason, Gunnar H, Køber, Lars, Olsen, Niels Thue, Torp-Petersen, Christian, Fosbøl, Emil, Bruun, Niels Eske, Schou, Morten, Ruwald, Anne-Christine

“…Abstract Aim We investigated temporal trends in major cardiovascular events following first-time myocardial infarction (MI) and trends in revascularization and…”
Get full text

Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project by Rosberg, Victoria, Vishram-Nielsen, Julie KK, Kristensen, Anna M. Dyrvig, Pareek, Manan, Sehested, Thomas S.G., Nilsson, Peter M, Linneberg, Allan, Palmieri, Luigi, Giampaoli, Simona, Donfrancesco, Chiara, Kee, Frank, Mancia, Giuseppe, Cesana, Giancarlo, Veronesi, Giovanni, Grassi, Guido, Kuulasmaa, Kari, Salomaa, Veikko, Palosaari, Tarja, Sans, Susana, Ferrieres, Jean, Dallongeville, Jean, Söderberg, Stefan, Moitry, Marie, Drygas, Wojciech, Tamosiunas, Abdonas, Peters, Annette, Brenner, Hermann, Schöttker, Ben, Grimsgaard, Sameline, Biering-Sørensen, Tor, Olsen, Michael H

“…To assess whether anthropometric measures (body mass index [BMI], waist-hip ratio [WHR], and estimated fat mass [EFM]) are independently associated with major…”
Get full text

Measures of overweight and obesity and risk of cardiovascular disease: a population-based study by Sehested, Thomas S G, Hansen, Tine W, Olsen, Michael H, Abildstrøm, Steen Z, Rasmussen, Susanne, Ibsen, Hans, Torp-Pedersen, Christian, Madsbad, Sten, Jeppesen, Jørgen

“…Although overweight and obesity are associated with cardiovascular disease (CVD), it is unclear which clinical measure of overweight and obesity is the…”
Get full text